BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27402365)

  • 1. The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.
    Song L; Li Y
    Stem Cell Rev Rep; 2016 Oct; 12(5):573-583. PubMed ID: 27402365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
    To KK; Leung WW; Ng SS
    Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis.
    Bormann F; Rodríguez-Paredes M; Lasitschka F; Edelmann D; Musch T; Benner A; Bergman Y; Dieter SM; Ball CR; Glimm H; Linhart HG; Lyko F
    Cell Rep; 2018 Jun; 23(11):3407-3418. PubMed ID: 29898408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.
    González B; Fece de la Cruz F; Samuelsson JK; Alibés A; Alonso S
    Sci Rep; 2018 Jul; 8(1):11097. PubMed ID: 30038405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
    Weisenberger DJ; Liang G; Lenz HJ
    Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
    Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
    Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.
    Patai ÁV; Valcz G; Hollósi P; Kalmár A; Péterfia B; Patai Á; Wichmann B; Spisák S; Barták BK; Leiszter K; Tóth K; Sipos F; Kovalszky I; Péter Z; Miheller P; Tulassay Z; Molnár B
    PLoS One; 2015; 10(8):e0133836. PubMed ID: 26291085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
    Jiang Y; Liu Z; Xu F; Dong X; Cheng Y; Hu Y; Gao T; Liu J; Yang L; Jia X; Qian H; Wen T; An G
    J Cell Mol Med; 2018 Oct; 22(10):4875-4885. PubMed ID: 29999571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
    Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER3 overexpression and hypomethylation in colorectal adenocarcinoma.
    Othman R; Mohtarrudin N; Ahmad Zubir NM; Seow HF; Ngan KW; Osman M
    Malays J Pathol; 2022 Apr; 44(1):67-74. PubMed ID: 35484888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of DNMT3b expression and SEPT9 methylation in theprogression of colorectal carcinogenesis].
    He N; Feng G; Dou JH; Tang GB; Qian MR; Chen L; Wu KC
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):925-930. PubMed ID: 33256303
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
    Zhao Y; Wang C; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.